Fentanyl Citrate Troche/Lozenge Shortage
Last Updated: September 24, 2024
Status: Discontinued
To Be Discontinued:
- Actiq, Troche/Lozenge, 1200 ug (Teva Pharmaceuticals USA, Inc.)
- Actiq, Troche/Lozenge, 1600 ug (Teva Pharmaceuticals USA, Inc.)
- Actiq, Troche/Lozenge, 200 ug (Teva Pharmaceuticals USA, Inc.)
- Actiq, Troche/Lozenge, 400 ug (Teva Pharmaceuticals USA, Inc.)
- Actiq, Troche/Lozenge, 600 ug (Teva Pharmaceuticals USA, Inc.)
- Actiq, Troche/Lozenge, 800 ug (Teva Pharmaceuticals USA, Inc.)
Actiq, Troche/Lozenge, 1200 ug (Teva Pharmaceuticals USA, Inc.)
NDC Code: 0093-7869-65Status: To Be Discontinued
Date of update: September 24, 2024
Update type: New
Related Information: Company Decision to Discontinue the Product
Therapeutic category: Analgesia/Addiction
Date discontinued: September 24, 2024
Initial posting date: September 24, 2024
Contact info: 800-545-8800
Actiq, Troche/Lozenge, 1600 ug (Teva Pharmaceuticals USA, Inc.)
NDC Code: 0093-7870-65Status: To Be Discontinued
Date of update: September 24, 2024
Update type: New
Related Information: Company Decision to Discontinue the Product
Therapeutic category: Analgesia/Addiction
Date discontinued: September 24, 2024
Initial posting date: September 24, 2024
Contact info: 800-545-8800
Actiq, Troche/Lozenge, 200 ug (Teva Pharmaceuticals USA, Inc.)
NDC Code: 0093-7865-65Status: To Be Discontinued
Date of update: September 24, 2024
Update type: New
Related Information: Company Decision to Discontinue the Product
Therapeutic category: Analgesia/Addiction
Date discontinued: September 24, 2024
Initial posting date: September 24, 2024
Contact info: 800-545-8800
Actiq, Troche/Lozenge, 400 ug (Teva Pharmaceuticals USA, Inc.)
NDC Code: 0093-7866-65Status: To Be Discontinued
Date of update: September 24, 2024
Update type: New
Related Information: Company Decision to Discontinue the Product
Therapeutic category: Analgesia/Addiction
Date discontinued: September 24, 2024
Initial posting date: September 24, 2024
Contact info: 800-545-8800
Actiq, Troche/Lozenge, 600 ug (Teva Pharmaceuticals USA, Inc.)
NDC Code: 0093-7867-65Status: To Be Discontinued
Date of update: September 24, 2024
Update type: New
Related Information: Company Decision to Discontinue the Product
Therapeutic category: Analgesia/Addiction
Date discontinued: September 24, 2024
Initial posting date: September 24, 2024
Contact info: 800-545-8800
Actiq, Troche/Lozenge, 800 ug (Teva Pharmaceuticals USA, Inc.)
NDC Code: 0093-7868-65Status: To Be Discontinued
Date of update: September 24, 2024
Update type: New
Related Information: Company Decision to Discontinue the Product
Therapeutic category: Analgesia/Addiction
Date discontinued: September 24, 2024
Initial posting date: September 24, 2024
Contact info: 800-545-8800
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.